HCRN-GU14-206

A phase II single arm multi-center trial evaluating the efficacy of pembrolizumab in the treatment of patients with incurable platinum refractory germ cell tumors

Status

Study Completed

Cancer Type(s)

Study Contact

Publications

Trial Locations

All sites in which the trial HCRN-GU14-206 being conducted in.
No data was found